{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T11:18:25Z","timestamp":1694258305893},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.clinthera.2014.12.019","type":"journal-article","created":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T21:02:42Z","timestamp":1422133362000},"page":"804-815","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom"],"prefix":"10.1016","volume":"37","author":[{"given":"Xiting","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Ejzykowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena R.","family":"Ramey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Sajjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baishali M.","family":"Ambegaonkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Mavros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaan","family":"Tunceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2014.12.019_bib1","unstructured":"British Heart Foundation. Coronary Heart Disease Statistics 2012. http:\/\/www.bhf.org.uk\/publications\/view-publication.aspx?ps=1002097."},{"key":"10.1016\/j.clinthera.2014.12.019_bib2","unstructured":"British Heart Foundation. Coronary Heart Disease Statistics. http:\/\/www.bhf.org.uk\/heart%20health\/facts%20and%20statistics.aspx."},{"key":"10.1016\/j.clinthera.2014.12.019_bib3","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0195-668X(03)00471-8","article-title":"Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to the aetiology of coronary heart disease: impact of regression dilution bias","volume":"24","author":"Emberson","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2014.12.019_bib4","unstructured":"British Heart Foundation. Modelling the UK burden of Cardiovascular Disease to 2020. http:\/\/www.bhf.org.uk\/get-involved\/campaigning\/cardio--vascular-coalition.aspx British Heart Foundation."},{"key":"10.1016\/j.clinthera.2014.12.019_bib5","series-title":"CHD: Estimating the Impact of Changes in Risk Factors","author":"McPherson","year":"2002"},{"key":"10.1016\/j.clinthera.2014.12.019_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2265.2006.02459.x","article-title":"Levels of dyslipidaemia and improvement in its management in England: Results from the Health Survey for England 2003","volume":"64","author":"Primatesta","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"25Suppl 2","key":"10.1016\/j.clinthera.2014.12.019_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2014.12.019_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","article-title":"An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia\u2014full report","volume":"8","year":"2014","journal-title":"J Clinical Lipidology"},{"key":"10.1016\/j.clinthera.2014.12.019_bib9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias. The Task Force on the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2014.12.019_bib10","article-title":"American Association of Clinical Endocrinologists\u2019 Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis","volume":"Vol 18","author":"Jellinger","year":"2012","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.clinthera.2014.12.019_bib11","article-title":"NICE Clinical Guideline CG181","year":"2014","journal-title":"Lipid Modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease"},{"key":"10.1016\/j.clinthera.2014.12.019_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacl.2014.07.007","article-title":"National Lipid Association Recommendation for Patient Centered Management of Dyslipidemia Part 1\u2013executive summary","volume":"8","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"Suppl2","key":"10.1016\/j.clinthera.2014.12.019_bib13","first-page":"ii1","article-title":"Joint British Societies\u2019 consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2014.12.019_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2014.12.019_bib15","first-page":"280","article-title":"Switching statins: the impact on patient outcomes","volume":"14","author":"Phillips","year":"2007","journal-title":"Br J Cardiol"},{"key":"10.1016\/j.clinthera.2014.12.019_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/07853890902729786","article-title":"Clinical review: impact of statin substitution policies on patient outcomes","volume":"41","author":"Atar","year":"2009","journal-title":"Ann Med"},{"key":"10.1016\/j.clinthera.2014.12.019_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2042098611435911","article-title":"Recent advances in utility and use of the General Practice Research Database as an example of a UK primary care data resource","volume":"3","author":"Williams","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.clinthera.2014.12.019_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jacl.2010.10.004","article-title":"Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease\/coronary heart disease-equivalent patients","volume":"4","author":"Tunceli","year":"2010","journal-title":"J Clin Lipidology"},{"issue":"Suppl 5","key":"10.1016\/j.clinthera.2014.12.019_bib19","first-page":"v1","article-title":"JBS 2: Joint British Societies\u2019 guidelines on prevention of cardiovascular disease in clinical practice","volume":"91","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2014.12.019_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/hrt.2004.053645","article-title":"Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients","volume":"92","author":"Capewell","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2014.12.019_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.atherosclerosis.2008.03.016","article-title":"Prevalence and predictors of lipid abnormalities in patients treated with statins in the UK general practice","volume":"202","author":"Phatak","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2014.12.019_bib22","article-title":"NICE Technology Appraisal TA94","year":"2006","journal-title":"Statins for the prevention of cardiovascular events"},{"key":"10.1016\/j.clinthera.2014.12.019_bib23","article-title":"NICE Clinical Guideline CG67","year":"2008","journal-title":"Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease"},{"key":"10.1016\/j.clinthera.2014.12.019_bib24","unstructured":"Heart Protection Study Collaborative Group. The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial. BMC Med Mar. 16;3:6."},{"key":"10.1016\/j.clinthera.2014.12.019_bib25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1742-1241.2010.02429.x","article-title":"Incremental cholesterol reduction with ezetimibe\/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets","volume":"64","author":"McCormack","year":"2010","journal-title":"Int J Clin Pract"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814008807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814008807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T02:24:52Z","timestamp":1537928692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814008807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0149291814008807"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.12.019","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}